1-7 of 7
Geoffrey D. Barnes
Close
Sort by
Journal Articles

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart, Scott Kaatz, Gregory D Krol, Suman L Sood, James Froehlich, Geoffrey D. Barnes
Journal: Blood
Blood (2023) 142 (Supplement 1): 135.
https://doi.org/10.1182/blood-2023-184457
Published: 2023
Journal Articles

Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Paul Dorby, Christopher Giuliano, Brian Haymart, Scott Kaatz, Jacob E Kurlander, Gregory D Krol, Sahana Shankar, Suman L Sood, James Froehlich, Geoffrey D. Barnes
Journal: Blood
Blood (2023) 142 (Supplement 1): 5129.
https://doi.org/10.1182/blood-2023-184907
Published: 2023
Journal Articles

Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin for Atrial Fibrillation and/or Venous Thromboembolic Disease

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Tina Alexandris-Souphis, Mona A Ali, Subhash Edupuganti, Brian Haymart, Scott Kaatz, Eva Kline-Rogers, Jay H Kozlowski, Gregory D Krol, Vinay Shah, Suman L Sood, James B Froehlich, Geoffrey D Barnes
Journal: Blood
Blood (2021) 138 (Supplement 1): 179.
https://doi.org/10.1182/blood-2021-146294
Published: 2021
Journal Articles

A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism

Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 788.
https://doi.org/10.1182/blood-2019-123067
Published: 2019
Journal Articles

Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent Indication

Jordan K Schaefer, MD, Yun Li, PhD, Xiaowen Kong, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Sahana R Shankar, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 787.
https://doi.org/10.1182/blood-2019-122526
Published: 2019
Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 220.
https://doi.org/10.1182/blood.V130.Suppl_1.220.220
Published: 2017
Journal Articles

A Comparison of Socioeconomic Factors in Patients Continuing Warfarin Versus Those Transitioning to Direct Oral Anticoagulants (DOACs) for Venous Thromboembolic Disease or Atrial Fibrillation

Jordan K. Schaefer, MD, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc
Journal: Blood
Blood (2016) 128 (22): 1179.
https://doi.org/10.1182/blood.V128.22.1179.1179
Published: 2016